Cullinan Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio4.34
P/S Ratio35.58
P/B Ratio1.200.960.901.58
Price/Tangible Book1.200.960.901.59
Enterprise Value Ratios
EV/Revenue18.75
Profitability & Returns
Return on Equity (ROE)-0.32%-0.31%0.23%-0.22%-0.40%
Return on Assets (ROA)-0.22%-0.23%-0.17%-0.13%-0.24%
Return on Invested Capital (ROIC)-2.14%-6.02%-0.90%-1.09%
Return on Capital Employed (ROCE)-0.33%-0.42%-0.24%-0.16%-0.30%
Leverage & Solvency Ratios
Debt/Equity0.000.010.01
Liquidity Ratios
Current Ratio13.5317.0721.0925.2514.82
Quick Ratio13.2316.6020.7724.7314.68
Efficiency Ratios
Asset Turnover0.06
Yield & Distribution Ratios
Earnings Yield-0.24%-0.35%0.23%-0.10%
FCF Yield-0.20%-0.31%-0.26%-0.06%
Buyback Yield-0.29%0.11%-0.08%-1.17%-20.88%